The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 3-Misleading Marketing Claims
- PMID: 35250400
- PMCID: PMC8887226
The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 3-Misleading Marketing Claims
Abstract
Background: A lack of understanding of the processes involved in the absorption and transfer of the ubiquinol form of Coenzyme Q10 has led to a situation in which incorrect marketing claims are being made for the absorption of ubiquinol supplements, possibly misleading physicians and patients in the selection of a Coenzyme Q10 supplement for heart health benefits.In clinical trials, the ubiquinone form of Coenzyme Q10 has been associated with significantly improved symptoms and survival in patients with heart failure and significantly improved heart function and reduced cardiovascular mortality in community-living senior citizens. The ubiquinone form is the more stable and more extensively researched form. The ubiquinol form is unstable by virtue of being an electron donor that is easily oxidized to the ubiquinone form. Nevertheless, insufficiently documented marketing claims are being made for ubiquinol supplements.
Methods: To investigate whether or not oral ubiquinol from supplements is absorbed in the ubiquinol form or ubiquinone form, our labs conducted 2 studies of the instability of ubiquinol supplements: a lab study of 13 ubiquinol products sold in the United States and an in vivo study of ubiquinol absorption in large dogs.
Results: In the lab study, 76% to 84% of the oral ubiquinol in the nutritional supplements was oxidized to ubiquinone at body temperature in an 8.2 pH solution simulating small intestinal juice. That is to say, much of the oral ubiquinol had been converted to ubiquinone in the sort of pH environment that it would encounter prior to absorption. In a similar fashion, the percentage of ubiquinol converted to ubiquinone increased as the capsule contents passed through the stomach and small intestines of the study dogs.
Conclusions: Based on the data from the lab study and the large dog study, we concluded that ubiquinol in commercial nutritional supplements will most likely be oxidized to ubiquinone before it reaches the absorption cells and that the Coenzyme Q10 in the ubiquinol supplements will be absorbed predominantly in the ubiquinone state, transfer into the lymph nodes predominantly in the ubiquinone state and be reduced back to ubiquinol in the lymphatic system.
Copyright © 2021 InnoVision Professional Media Inc.
Similar articles
-
The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 2-Dog Studies.Integr Med (Encinitas). 2021 Oct;20(5):26-30. Integr Med (Encinitas). 2021. PMID: 34803537 Free PMC article. Review.
-
The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 1-Lab Studies.Integr Med (Encinitas). 2021 Aug;20(4):24-28. Integr Med (Encinitas). 2021. PMID: 34602873 Free PMC article. Review.
-
Orally ingested ubiquinol-10 or ubiquinone-10 reaches the intestinal tract and is absorbed by the small intestine of mice mostly in its original form.J Clin Biochem Nutr. 2023 Mar;72(2):101-106. doi: 10.3164/jcbn.22-91. Epub 2022 Dec 8. J Clin Biochem Nutr. 2023. PMID: 36936872 Free PMC article.
-
Rapid and sensitive analysis of reduced and oxidized coenzyme Q10 in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and application to studies in healthy human subjects.Ann Clin Biochem. 2016 Mar;53(Pt 2):265-73. doi: 10.1177/0004563215593097. Epub 2015 Jun 8. Ann Clin Biochem. 2016. PMID: 26056391 Free PMC article.
-
Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.Clin Pharmacol Drug Dev. 2014 Jan;3(1):13-7. doi: 10.1002/cpdd.73. Epub 2013 Oct 8. Clin Pharmacol Drug Dev. 2014. PMID: 27128225
Cited by
-
Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality.Curr Cardiol Rep. 2023 Dec;25(12):1759-1767. doi: 10.1007/s11886-023-01992-6. Epub 2023 Nov 16. Curr Cardiol Rep. 2023. PMID: 37971634 Free PMC article. Review.
References
-
- Judy WV. Coenzyme Q10: The Substances That Powers Life, An Insider’s Guide. Haderslev, Denmark: Ny Videnskab. 2018; pp. 35-37. ISBN: 978-87-7776-186-7.
-
- Littarru Lamprechts P. Coenzyme Q10: multiple benefits in one ingredient. OCL. 2011;18(2):76-82.
-
- Mortensen SA, Rosenfeldt F, Kumar A, et al. Q-SYMBIO Study Investigators . The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 20142(6):641-649. - PubMed
-
- Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013;167(5):1860-1866. - PubMed
-
- Alehagen U, Aaseth J, Alexander J, Johansson P. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. Plos One. 2018: 13(4)::e0193120. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous